SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-002849
Filing Date
2020-05-15
Accepted
2020-05-15 17:06:46
Documents
97
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 651887
2 CERTIFICATION curr_ex311.htm EX-31.1 8825
3 CERTIFICATION curr_ex312.htm EX-31.2 9401
4 CERTIFICATION curr_ex321.htm EX-32.1 3609
5 CERTIFICATION curr_ex322.htm EX-32.2 3473
12 curr_10qimg1.jpg GRAPHIC 7260
  Complete submission text file 0001477932-20-002849.txt   4979700

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20200331.xml EX-101.INS 864862
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20200331.xsd EX-101.SCH 95716
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20200331_lab.xml EX-101.LAB 457645
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20200331_cal.xml EX-101.CAL 34148
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20200331_pre.xml EX-101.PRE 389674
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20200331_def.xml EX-101.DEF 233830
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 20886628
SIC: 2673 Plastics, Foil & Coated Paper Bags